As reviewed above, NR4A1 limits the anti-tumor activity of tumor-infiltrating CD8+ T cells, NK cells, and B cells, while enhancing the immunosuppressive functions of Tregs [26,65]. The gene discussed is CD8A; the disease is neoplasm.